Fosamax is a drug prescribed to people suffering from osteoporosis or Pagets disease. Although Fosamax was approved by the FDA in 1995, and has been prescribed to millions of people over the past 10 years, new studies are showing that there is a link between Fosamax and a degenerative bone disease called Osteonecrosis of the Jaw (ONJ).

Fosamax is a type of drug called a bisphosphonate, and Merck manufactures it; its generic drug name is Alendronate Sodium. Fosamax changes the way bone tissue regenerates, and in patients with bone diseases like osteoporosis, or cancer, it slows bone loss.

Currently, lawsuits are being filed against Merck and other drug companies that produce bisphosphonates because they have been connected to Osteonecrosis of the Jaw (ONJ or Dead Jaw).

According to the Journal of Oral and Maxillofacial Surgeons, patients suffering from bone diseases, who are taking Fosamax, or any other bisphosphonate drug, can suffer Dead Jaw if they suffer trauma to their jawbone. This has occurred in patients taking Fosamax, who then had to under go a tooth extraction, or other dental procedure.

Osteonecrosis causes the bone tissue to be unable to heal itself after minor trauma. When a patient taking Fosamax undergoes a tooth extraction, the bone is unable to heal, and is left exposed. This can lead to the patient having to undergo antibiotic therapy, or even having the dead bone tissue removed.

If you or a loved one is currently taking or has taken Fosamax, and are now suffering from osteonecrosis of the jaw, you may be able to recover compensation from the losses you have endured. In order to learn more about Fosamax, or to file a claim against the maker of Fosamax, contact the experienced dangerous drug attorneys at DeMayo Law Offices, L.L.P.®

Our lawyers will work with you to determine if your ONJ is a direct result of taking Fosamax. They will also provide you with a free initial consultation where they will help you identify the best course of action to take and what losses you have endured that you may be able to recover compensation for. Contact DeMayo Law Offices, L.L.P. ® today to schedule your free initial consultation.

What Our clients are saying
Office Locations

With North Carolina office locations in Charlotte, Hickory, Monroe and in Columbia, South Carolina, DeMayo Law Offices have been serving the state since 1992. You can contact us 24/7 and if you are unable to come to us - we will come to you.


Provide the below information and we will contact you.

  • This field is for validation purposes and should be left unchanged.
Phone icon
Call Us 24/7
Location icon
home icon
We Come
To You

Please do not include any confidential or sensitive information in this form. This form sends information by non-encrypted email which is not secure. Submitting this form does not create an attorney-client relationship.

Member of the Multi-Million Dollar Advocates Forum Member of the Million Dollar Advocates Forum Top 100 Trial Lawyers North Carolina Advocates for Justice
AV Preeminent Client Champion DeMayo Law Offices is a BBB Accredited Business Rated by Super Lawyers

Membership in the Million Dollar Advocates Forum is limited to attorneys who have won million and multi-million dollar verdicts and settlements. Criteria for membership in Million Dollar Advocates can be found by clicking here. DeMayo Law Offices, L.L.P. does not represent that similar results will be achieved in your case. Each case is different and must be evaluated separately.

The National Trial Lawyers is a national organization composed of the Top 100 Trial Lawyers from each state. Membership is obtained through special invitation and is extended only to those attorneys who exemplify superior qualifications, leadership, reputation, influence, stature, and profile as trial lawyers, both civil plaintiff and criminal defense. More information can be found at the National Trial Lawyers web site by clicking here. DeMayo Law Offices, L.L.P. does not represent that similar results will be achieved in your case. Each case is different and must be evaluated separately.